Mithril Capital Management
VC Fund
San Francisco, United States
Mithril Capital Management is a VC fund in San Francisco focused on Software and Health Care. Mithril is a family of long-term venture capital funds agnostic to sector and geography. They provide capital to leading growth companies by partnering with teams who use technology to build transformative and durable businesses.
- Total investments:
- 70
- Last investment:
- Lead investor:
- 36%
- Fund size:
- $850M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Mithril Capital Management invests in
Stages Mithril Capital Management invests in
Countries Mithril Capital Management invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
1 more contact available
Round size
- Series B
- $10M–$150M
- Series C
- $15M–$142M
- Series D
- $15M–$300M
Investment Focus
Industry
- Software 12 (17%)
- Health Care 8 (11%)
- Enterprise Software 7 (10%)
- Information Technology 7 (10%)
- Medical Device 6 (9%)
Stage
- Series C 12 (17%)
- Series B 11 (16%)
- Series D 10 (14%)
- Series A 7 (10%)
- Series E 7 (10%)
Country
- United States 26 (37%)
- United Kingdom 4 (6%)
- Israel 2 (3%)
- India 1 (1%)
- Germany 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Anuja Royan
Managing Director
|
Managing Director | Total investments: 0 | Find email | |
Paul Leggett
Managing Director
|
Managing Director | Total investments: 0 | Find email | |
Ajay Royan
Founder & Managing General Partner
|
Founder & Managing General Partner | Total investments: 26 | Find email | |
Peter Thiel
Co-Founder
|
Co-Founder | Total investments: 234 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Helion Energy
|
Operator of a patented plasma accelerator technology designed to address the growing need for clean energy. The company's technology specializes in designing fusion generators based on magneto-inertial fusion with a fifty-megawatt module and energy regeneration, thereby enabling customers to use low-cost, clean, and safe energy. | $465M / Series G / Jun 04, 2026 | |
|
Helion Energy
|
Operator of a patented plasma accelerator technology designed to address the growing need for clean energy. The company's technology specializes in designing fusion generators based on magneto-inertial fusion with a fifty-megawatt module and energy regeneration, thereby enabling customers to use low-cost, clean, and safe energy. | $425M / Series F / Jan 28, 2025 | |
GreyOrange
|
GreyOrange is a global company that modernizes order fulfillment through Artificial Intelligence-driven software and mobile robots built together so they cooperate in deciding on and executing warehouse activities that maximize payoffs and minimize tradeoffs to create the highest yield. The company’s always-solving fulfillment operating systemGreyMatter considers predictive and real time data regarding orders, promises, inventory, shipping windows, and resources to orchestrate how workers and robots work together to fulfill the right orders at the right time. GreyOrange experts help organizations master fulfillment in the Age of Immediacy so they keep promises, capture more revenue, and improve the work experience for warehouse employees. GreyOrange has core operations in the United States, Singapore, Germany, Japan and India. | $135M / Series D / Dec 20, 2023 | |
Neocis
|
Neocis develops robot-assisted dental implant surgery with the aim of transforming dental surgery using advanced robotics. The company is the developer and manufacturer of Yomi, a robotic device for dental surgery commercially available in the USA and was cleared by the U.S. Food and Drug Administration. The company created Yomi aiming to focuson enhancing dental surgeons’ capabilities and advancing patient care through the latest technology. Neocis operates with dental surgeons to understand the needs with the focus on overcoming surgical and treatment challenges. Neocis was founded in 2009 and is headquartered in Miami, Florida. | $40M / Series D / Oct 27, 2022 | |
Genetesis
|
Genetesis is a rapidly growing medical technology company redefining the way patients with a risk of myocardial ischemia and coronary artery disease are clinically diagnosed, monitored and screened. | $17.5M / Series C / Oct 06, 2022 | |
Juno
|
OnJuno is a cross-border banking platform that aims to give users across the world a high yield account to grow their savings. Going live in the US, OnJuno is taking a radical approach towards creating an open and global banking system for everyone, regardless of their location or income. | $18M / Series A / Oct 01, 2022 | |
|
Juno
|
OnJuno is a cross-border banking platform that aims to give users across the world a high yield account to grow their savings. Going live in the US, OnJuno is taking a radical approach towards creating an open and global banking system for everyone, regardless of their location or income. | $18M / Series A / Oct 01, 2022 | |
Fractyl Health
|
Fractyl Health develops innovative medical device solutions for the treatment of chronic diseases. The growing product pipeline leverages our minimally invasive procedural therapy, Revita DMR (duodenal mucosal resurfacing), which is designed to rejuvenate the lining of the duodenum and improve patient health. They envision a world with bettersolutions to chronic diseases through the use of less invasive, device-based therapies that will lessen the burden on patients, physicians, and payers.Fractyl Health aims to bring curative therapies to the large populations of patients with metabolic disease. | Series F / Aug 15, 2022 | |
ForSight Robotics
|
ForSight Robotics develops a surgical robotic platform to deliver high precision and cost-effective vision-saving surgery. | $55M / Series A / Jul 18, 2022 | |
Oma Fertility
|
Oma Fertility is a full-service fertility clinic that offers fertility care and treatments. It brings top lab design and technology to in-house treatments like IUI and IVF, coordinates seamlessly with third parties like surrogate agencies and egg and sperm banksOma uses Oma Sperm InSight and their proprietary AI microscope, which together helptheir embryologists select the most promising sperm cell for IVF. | $29M / Venture - Series Unknown / Jun 20, 2022 | |
| See all 70 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Mithril Capital Management invest in?
Mithril Capital Management invests primarily in Software, Health Care and Enterprise Software startups, most often at Series C and Series B stage. Most of the 70 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Mithril Capital Management's check size?
Mithril Capital Management typically joins rounds of $10M–$150M at Series B, $15M–$142M at Series C and $15M–$300M at Series D. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Mithril Capital Management participates in.
How do I contact Mithril Capital Management?
Public channels for Mithril Capital Management include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Mithril Capital Management?
The team at Mithril Capital Management includes Anuja Royan (Managing Director), Paul Leggett (Managing Director) and Ajay Royan (Founder & Managing General Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
